This phase I/II trial studies the side effects and best dose of aerosolized aldesleukin and
to see how well it works in treating patients with cancer that has spread from the original
tumor to the lungs. Biological therapies, such as aerosolized aldesleukin, may stimulate or
suppress the immune system in different ways and stop tumor cells from growing.